-
F133221-5gAn Fmoc protected glycine derivative.
-
F110979-100gFmoc-Thr(tBu)-OH.
-
F110979-1gFmoc-Thr(tBu)-OH.
-
F110979-25gFmoc-Thr(tBu)-OH.
-
F110979-500gFmoc-Thr(tBu)-OH.
-
F110979-5gFmoc-Thr(tBu)-OH.
-
F116847-1gFmoc-Thr(tBu)-OPfp.
-
F116847-25gFmoc-Thr(tBu)-OPfp.
-
F116847-5gFmoc-Thr(tBu)-OPfp.
-
F116800-100gFmoc-Trp(Boc)-OH can be used for the synthesis of analogs of Glukagon-like peptide-1 (GLP-1) for the treatment of type 2 diabetes[1] and various peptides by Fmoc solid phase peptide synthesis (SPPS).
-
F116800-1gFmoc-Trp(Boc)-OH can be used for the synthesis of analogs of Glukagon-like peptide-1 (GLP-1) for the treatment of type 2 diabetes[1] and various peptides by Fmoc solid phase peptide synthesis (SPPS).
-
F116800-25gFmoc-Trp(Boc)-OH can be used for the synthesis of analogs of Glukagon-like peptide-1 (GLP-1) for the treatment of type 2 diabetes[1] and various peptides by Fmoc solid phase peptide synthesis (SPPS).